Neogenomics NEO
NASDAQ NEO
$19.45 +0.05 (+0.23%)
As of: Sep 22, 2026 · 10:07 AM EDT

Neogenomics (NEO) Net Income towards Common Stockholders (2010 - 2026)

Neogenomics' (NEO) quarterly Net Income towards Common Stockholders came in at $2.2 million in Q2 2026, up 104.96% on a YoY basis from $1.1 million in Q2 2025, and up 113.08% quarter-over-quarter from -$17.1 million in Q1 2026.

Analysis

Neogenomics (NEO) Net Income towards Common Stockholders (2010 - 2026) Analysis & Trends

Neogenomics (NEO) has reported Net Income towards Common Stockholders for 17 consecutive years, with $2.2 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Net Income towards Common Stockholders rose 104.96% year-over-year to $2.2 million; the trailing twelve-month figure through Jun 2026 stood at -$51.9 million (up 50.14% YoY), and the FY2025 full-year result was -$108.0 million, down 37.22% from the prior year.
  • Net Income towards Common Stockholders grew to $2.2 million in Q2 2026 per NEO's latest filing, from -$17.1 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at $2.2 million in Q2 2026 and bottomed at -$49.4 million in Q1 2022.
  • Historically, Net Income towards Common Stockholders has averaged -$24.1 million across 5 years, with a median of -$23.5 million in 2022.
  • The sharpest annual moves came in 2022 and 2026: Net Income towards Common Stockholders plunged 146.53% in 2022, then surged 104.96% in 2026.
  • Over 5 years, Net Income towards Common Stockholders stood at -$22.7 million in 2022, then soared by 36.85% to -$14.3 million in 2023, then dropped by 6.97% to -$15.3 million in 2024, then surged by 35.52% to -$9.9 million in 2025, then jumped by 122.65% to $2.2 million in 2026.
  • According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered $2.2 million, -$17.1 million, and -$9.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Natera 53.05 Bn 51.95 Bn 486.15 Mn -66.93 Mn
2 Quest Diagnostics 27.19 Bn 26.87 Bn 1.03 Bn 324.00 Mn
3 Labcorp Holdings 25.93 Bn 25.81 Bn 1.11 Bn 299.10 Mn
4 Guardant Health 23.97 Bn 22.91 Bn 219.03 Mn -120.14 Mn
5 Tempus AI 13.64 Bn 12.82 Bn 274.25 Mn 8.51 Mn
6 Caris Life Sciences 8.47 Bn 7.68 Bn 182.38 Mn -637,000.00
7 Sotera Health 5.35 Bn 4.99 Bn 177.96 Mn 53.64 Mn
8 BillionToOne 4.96 Bn 4.41 Bn 77.11 Mn 8.05 Mn
9 Adaptive Biotechnologies 4.55 Bn 4.21 Bn 51.39 Mn -16.21 Mn
10 Neogenomics 2.55 Bn 2.40 Bn 91.88 Mn 2.24 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.24 Mn
Mar 31, 2026 -17.11 Mn
Dec 31, 2025 -9.88 Mn
Sep 30, 2025 -27.13 Mn
Jun 30, 2025 -45.09 Mn
Mar 31, 2025 -25.92 Mn
Dec 31, 2024 -15.32 Mn
Sep 30, 2024 -17.70 Mn
Jun 30, 2024 -18.64 Mn
Mar 31, 2024 -27.06 Mn
Dec 31, 2023 -14.33 Mn
Sep 30, 2023 -18.52 Mn
Jun 30, 2023 -24.33 Mn
Mar 31, 2023 -30.80 Mn
Dec 31, 2022 -22.69 Mn
Sep 30, 2022 -36.85 Mn
Jun 30, 2022 -35.30 Mn
Mar 31, 2022 -49.41 Mn
Dec 31, 2021 -41.76 Mn
Sep 30, 2021 -20.35 Mn
API Access

Neogenomics Net Income towards Common Stockholders API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=NEO&period=max&api_key=YOUR_API_KEY